These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1280687)

  • 1. Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
    McCool RA; Bombard AT; Bartholomew DA; Calhoun BC
    J Reprod Med; 1992 Sep; 37(9):826-8. PubMed ID: 1280687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
    Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
    Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
    Kupferminc MJ; Tamura RK; Wigton TR; Glassenberg R; Socol ML
    Obstet Gynecol; 1993 Aug; 82(2):266-9. PubMed ID: 7687756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case report of placenta praevia reflexa et increta].
    Gitsch G
    Geburtshilfe Frauenheilkd; 1988 Aug; 48(8):603-5. PubMed ID: 3215455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta.
    Ollendorff DA; Goldberg JM; Abu-Jawdeh GM; Lurain JR
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):494-7. PubMed ID: 1696367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening obstetric haemorrhage in second trimester from a placenta percreta with raised alpha-fetoprotein levels.
    Kapoor DS; Tincello DG; Kingston RE
    J Obstet Gynaecol; 2003 Sep; 23(5):570-1. PubMed ID: 12963529
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Placenta accreta with placenta previa after previous cesarean sections--a growing danger in modern obstetrics].
    Lachman E; Mali A; Gino G; Burstein M; Stark M
    Harefuah; 2000 Apr; 138(8):628-31, 712. PubMed ID: 10883200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
    McDuffie RS; Harkness L; McVay RM; Haverkamp AD
    Am J Obstet Gynecol; 1994 Aug; 171(2):565-6. PubMed ID: 7520215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
    Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
    Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of maternal serum alpha-fetoprotein with persistent placenta previa.
    Koster EL; Dashe JS; McIntire DD; Ramus RM
    J Matern Fetal Neonatal Med; 2004 Jul; 16(1):3-7. PubMed ID: 15370075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta previa accreta membranacea.
    Bukovsky I; Hirsch H
    Int Surg; 1971 Dec; 56(6):422-5. PubMed ID: 5129716
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
    Killam WP; Miller RC; Seeds JW
    Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.